HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The natural history of Leber's congenital amaurosis. Age-related findings in 35 patients.

Abstract
The authors studied 35 patients with Leber's congenital amaurosis and assessed visual acuity, fundus appearance, and systemic findings. The patients were arbitrarily divided into five age groups. Visual acuities were comparable at all ages. Of 22 patients seen for follow-up examinations (mean length of follow-up, 5 years), vision worsened slightly in only 4 patients (3 with macular coloboma-like lesions and 1 with keratoconus). Fifty percent of retinal examinations in patients younger than 1 year of age were normal. With increasing age, retinal pigmentary changes became evident. All but four patients seen on more than one occasion developed progressive retinal/retinal pigment epithelium changes. Cataracts (5 patients) and keratoconus (3 patients) were present only in older patients (9 to 33 years of age). In Leber's congenital amaurosis, which probably comprises a number of genetically heterogenous conditions, visual acuity remains stable despite progressive retinal pigmentary changes. The subgroup of patients with macular colobomas, however, may develop progressive decrease in vision. Cataracts and keratoconus are additional factors contributing to visual impairment in older patients.
AuthorsK L Heher, E I Traboulsi, I H Maumenee
JournalOphthalmology (Ophthalmology) Vol. 99 Issue 2 Pg. 241-5 (Feb 1992) ISSN: 0161-6420 [Print] United States
PMID1553215 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Aging (physiology)
  • Cataract (etiology)
  • Child
  • Child, Preschool
  • Coloboma (etiology)
  • Corneal Diseases (etiology)
  • Female
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Infant
  • Macula Lutea (abnormalities)
  • Male
  • Optic Atrophies, Hereditary (physiopathology)
  • Retinal Diseases (etiology)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: